Evaluation of stratum corneum structure before and after administration of biopharmaceutics in Psoriasis vulgaris patients

Evaluation of stratum corneum structure before and after administration of biopharmaceutics in Psoriasis vulgaris patients - Evaluation of stratum corneum structure before and after administration of biopharmaceutics in Psoriasis vulgaris patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030294

Enrollment

Registered

2017-12-07

Start date

2017-09-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis vulgaris, Arthropathy of psoriasis

Interventions

Evaluation of the stratum corneum structure before and after biopharmaceutics in psoriasis patients The stratum corneum of patients will be removed by tape stripping method on day 0, 14, 28, 56, 84

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who are diagnosed with vulgarity or arthropathic psoriasis 2. More than 20-years olds patients at the time of enrollement

Exclusion criteria

Exclusion criteria: 1. Patients with a history of allergy for the biopharmaceutics 2. Patients who are considered to be inappropriate in enrollment of this trial by attending physicians

Design outcomes

Primary

Measure	Time frame
Relationship between composition and structure of stratum coreum and clinical condition (PASI score)	—

Countries

Japan

Contacts

Public ContactTomonobu Uchino

University of Shizuoka Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences,

uchinot@u-shizuoka-ken.ac.jp054-264-5771

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026